| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.1 |